Kinnate Biopharma Inc. 6KB.MU Stock
Kinnate Biopharma Inc. Price Chart
Kinnate Biopharma Inc. 6KB.MU Financial and Trading Overview
| Kinnate Biopharma Inc. stock price | 2.42 EUR |
| Previous Close | 2.96 EUR |
| Open | 3.02 EUR |
| Bid | 3.02 EUR x N/A |
| Ask | 3.1 EUR x N/A |
| Day's Range | 3.02 - 3.02 EUR |
| 52 Week Range | 2.18 - 15.3 EUR |
| Volume | 600 EUR |
| Avg. Volume | 0 EUR |
| Market Cap | 140.65M EUR |
| Beta (5Y Monthly) | 0.185111 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.57 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
6KB.MU Valuation Measures
| Enterprise Value | -49865604 EUR |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.6314029 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | 0.398 |
Trading Information
Kinnate Biopharma Inc. Stock Price History
| Beta (5Y Monthly) | 0.185111 |
| 52-Week Change | -60.25% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 15.3 EUR |
| 52 Week Low | 2.18 EUR |
| 50-Day Moving Average | 3.87 EUR |
| 200-Day Moving Average | 7.01 EUR |
6KB.MU Share Statistics
| Avg. Volume (3 month) | 0 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 46.57M |
| Float | 18.11M |
| Short Ratio | N/A |
| % Held by Insiders | 0.39% |
| % Held by Institutions | 93.66% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -26.60% |
| Return on Equity (ttm) | -44.18% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -125366000 EUR |
| Net Income Avi to Common (ttm) | -122309000 EUR |
| Diluted EPS (ttm) | -2.31 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 200.98M EUR |
| Total Cash Per Share (mrq) | 4.32 EUR |
| Total Debt (mrq) | 3.95M EUR |
| Total Debt/Equity (mrq) | 1.77 EUR |
| Current Ratio (mrq) | 11.308 |
| Book Value Per Share (mrq) | 4.783 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -95667000 EUR |
| Levered Free Cash Flow (ttm) | -53977876 EUR |
Profile of Kinnate Biopharma Inc.
| Country | Germany |
| State | CA |
| City | San Francisco |
| Address | 103 Montgomery Street |
| ZIP | 94129 |
| Phone | 858 299 4699 |
| Website | https://www.kinnate.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 94 |
Kinnate Biopharma Inc., a clinical-stage oncology company, focuses on the discovery and development of small molecule kinase inhibitors to treat genomically defined cancers in the United States. The company develops KIN-2787, a rapidly accelerated fibrosarcoma inhibitor for the treatment of patients with lung cancer, melanoma, and other solid tumors; KIN-3248 small-molecule kinase inhibitors that target cancer-associated alterations in fibroblast growth factor receptors FGFR2 and FGFR3 genes; and small molecule research programs, including Cyclin-Dependent Kinase 12(CDK12) inhibitor in its KIN004 program. The company was incorporated in 2018 and is headquartered in San Francisco, California. Kinnate Biopharma Inc. is a former subsidiary of Fount Therapeutics, LLC.
Q&A For Kinnate Biopharma Inc. Stock
What is a current 6KB.MU stock price?
Kinnate Biopharma Inc. 6KB.MU stock price today per share is 2.42 EUR.
How to purchase Kinnate Biopharma Inc. stock?
You can buy 6KB.MU shares on the Munich exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Kinnate Biopharma Inc.?
The stock symbol or ticker of Kinnate Biopharma Inc. is 6KB.MU.
Which industry does the Kinnate Biopharma Inc. company belong to?
The Kinnate Biopharma Inc. industry is Biotechnology.
How many shares does Kinnate Biopharma Inc. have in circulation?
The max supply of Kinnate Biopharma Inc. shares is 48.04M.
What is Kinnate Biopharma Inc. Price to Earnings Ratio (PE Ratio)?
Kinnate Biopharma Inc. PE Ratio is now.
What was Kinnate Biopharma Inc. earnings per share over the trailing 12 months (TTM)?
Kinnate Biopharma Inc. EPS is -2.57 EUR over the trailing 12 months.
Which sector does the Kinnate Biopharma Inc. company belong to?
The Kinnate Biopharma Inc. sector is Healthcare.